eGenesis is a Massachusetts-based biotechnology company that researches and develops human-compatible organs, tissues, and cells to treat patients with organ failure.
$191M
Sep 03, 2024
-
$24M
Aug 05, 2024
-
RecoMed is an online healthcare platform that allows users to discover and book appointments.
-
Mar 07, 2024
-
Casma is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders.
$46M
Nov 14, 2022
-
Oura is a Finland-based medical device company that develops and sells oura rings that help individuals to track and monitor sleep and physical activities.
$100M
May 03, 2021
-
Frequently Asked Questions about Eisai
What is Eisai investing in?
Eisai has invested in 8 companies including eGenesis, Seed Therapeutics and RecoMed
What company did Eisai invest in?
Eisai invested in a total 8 companies including eGenesis, Seed Therapeutics and RecoMed
What are the top 5 investments by Eisai?
The top companies in which Eisai invested are eGenesis, Seed Therapeutics, RecoMed, Casma and Oura
